Clinical Trials Browser

Phase 2 × INDUSTRY × lestaurtinib × Clear all

NCT00079482 2016-07-21

Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00586651 2015-10-08

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

Phase 2 Completed

Polycythemia Vera, Thrombocythemia, Essential

NCT00081601 2012-08-24

Study of CEP-701 in Treatment of Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00030186 2012-08-23

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid

NCT00242827 2012-08-23

Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma

Phase 2 Terminated

Neoplasms, Plasma Cell